The Food Standards Agency (FSA) of the UK has recently updated its guidelines regarding the daily intake of cannabidiol (CBD). This article delves deep into the implications of these new guidelines, the historical context, comparisons with other countries’ regulations, and the science behind CBD dosage recommendations.
CBD, or cannabidiol, is one of many chemicals known as cannabinoids found within hemp and cannabis plants. It can also be produced synthetically. CBD extracts can be derived from most parts of these plants and can be selectively extracted to concentrate CBD. However, some processes can alter other chemical components. In the UK,
CBD products are sold as foods, often as food supplements. These include oils, drops, tinctures, sprays, gel capsules, sweets, confectionery, bread, bakery products, and drinks. Learn more.
In October 2023, the FSA issued updated precautionary advice on CBD. The new guidelines recommend that healthy adults should limit their consumption of CBD from food to 10mg per day. To put this into perspective, this is approximately 4-5 drops of 5% CBD oil. This change in advice is based on new evidence from the industry and updated advice from the FSA’s independent scientific committee.
The more CBD you consume over your lifetime, the more likely you are to develop long-term adverse effects, such as liver damage or thyroid issues.
The new guidelines have significant implications for various stakeholders:
CBD has gained immense popularity over the past few years. However, its safety and efficacy are still under research. The FSA’s guidelines have evolved based on the available evidence. The current guidelines are a result of continuous monitoring and assessment of CBD’s impact on health.
While the UK’s FSA has set its guidelines, other countries may have different regulations. It’s essential to understand and respect the local guidelines when purchasing or consuming CBD products abroad.
The Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT) and the Advisory Committee on Novel Foods and Processes (ACNFP) have published advice on CBD. The Scientific Advisory Committee (SAC) continues to monitor new data. If new data changes the SAC’s view, the FSA will consider impacts on consumer advice.
The FSA’s new guidelines on daily CBD intake aim to ensure the safety of consumers. As research on CBD continues, it’s crucial for consumers to stay informed and make choices that prioritize their health and well-being.
Note: Always consult with a healthcare professional before consuming CBD products.
